Then and Now: This Month in Endocrine History Submitted by Evan Graber, DO In 1958, in a Letter to the…
More Articles
Fri 16 October 16, 2020 / 2:00 pm – 4:30 pm PES Leadership Advantage FALL MODULE OFFERING Since our virtual, live delivery of the INFLUENCE module in May was a…
PES Going Virtual for 2021 We are pleased to announce the dates for the PES 2021 VIRTUAL Annual Meeting! April 30th- May 3rd, 2021 We are excited to think innovatively…
Prepared by Bhuvana Sunil, MD and Ambika Ashraf, MD Burosumab twza (Crysvita – Ultragenyx pharmaceuticals) is an injectable recombinant IgG1 human monoclonal antibody preparation neutralizing fibroblast growth factor 23 (FGF-23).…
My name is Iman, and I just started the third year of my pediatric endocrinology fellowship at Baylor College of Medicine/Texas Children’s Hospital. I consider myself a global citizen, as…
Name: Amanda Barks Year: G5/MS3 (Defending thesis and returning to clinic summer 2020) Program: MD/PhD School: University of Minnesota Medical School What is your most…
Name: Meredith Hanrahan Year: 3rd Year Medical Student (Class of 2022) Program: M.D. Program School: Geisinger Commonwealth School of Medicine What is your most memorable experience in…
Prepared by Christine Yu and Amit Lahoti Semglee™ is a new biosimilar insulin with an identical amino-acid sequence to insulin glargine. Semglee™, co-developed by Mylan Inc. and Biocon Ltd., was…
Prepared by: Seth Marks and Amit Lahoti Updated July 22, 2020 The FreeStyle Libre 2 is the second generation of Abbott Laboratories’ flash glucose monitoring system. It was approved by…
These resources have been identified by members as being useful during these difficult times. They are provided as a reference only. Timely information about COVID-19 that is curated specifically for…
Riomet ER™ (metformin hydrochloride for extended-release oral suspension) was approved by the U.S. Food and Drug Administration (USFDA) on August 29, 2019 and became available in the US at the…